Discover the very best surgical and non-surgical penile enlargement procedures
We provide more paths to a bigger you than all our competitors combined
Guaranteed Length Options
Guaranteed Penile Lengthening (1-Inch & 2-Inch Options)
Board-certified urologists • documented measurement standards • eligibility-based guarantees
Rejuvall offers guaranteed length outcomes for qualified patients—because your plan is built around anatomy, not hype.
How Rejuvall gets predictable results
Penile enlargement is not “one procedure.” It’s anatomy + diagnosis + technique. Rejuvall offers 33+ pathways because men vary in fat pad anatomy, skin availability, scrotal webbing, vascular health, and prior procedures.
For instance, what would happen if we attempted to merely add thickness to a man with a swollen fat pad? His penis would actually become shorter after the procedure.
If we were to add length to a patient with significant scrotal webbing, the part with hair follicles would wind up too high on the shaft, causing intimacy-related discomfort for his partner.
That’s also why we do this as urologists—the penis is an organ with blood flow, nerves, erectile tissue, and connective structures that must be preserved.
We don’t use high-risk, non-medical injectables or “mystery fillers.” If a plan sounds too fast or too easy, it usually is.
The core factors that determine your best length pathway include:
- Surgical vs. non-surgical approach (including MAXL®)
- Existing anatomy (fat pad, skin availability, webbing)
- Health variables (A1C, smoking, vascular status)
- Prior procedures or scar tissue
- Recovery window and budget
Rejuvall’s Guarantee
Our clinics guarantee a minimum penile length increase for many patients. See exceptions below.
The Only Clinic that Guarantees Results
How many times have you seen phrases like “patients have reported” or “some patients attained,” only to be informed “everyone is different” when you inquire about what is guaranteed following penis enlargement surgery?
Many clinics make empty promises, while others provide personal assurance.
Rejuvall’s Length Guarantee (Eligibility-Based)
For qualified candidates, Rejuvall offers documented minimum length guarantees using standardized measurement methods and a defined protocol.
If a qualified patient does not meet the guaranteed minimum length outcome, Rejuvall will provide a resolution pathway (which may include additional treatment planning or financial remedy) based on the patient’s case, documentation, and clinical eligibility.
Note: eligibility and exclusions apply. Your consultant will review candidacy before scheduling.
Rejuvall 1-Inch Length Guarantee (MegaMAXL® 6:1)
Qualified patients who undergo MegaMAXL® 6:1 (surgical penile repositioning) receive a minimum +1 inch increase in documented flaccid visible length, measured using standardized clinical technique.
Rejuvall does not rely on “ligament release only” claims. Our approach prioritizes structural stability and functional integrity—not temporary hang.
Therefore, we are able to promise a guaranteed minimum length increase, whereas other clinics offer no such assurances.
We promise at least 1 inch of increased flaccid penile length after each Rejuvall MegaMAXL 6:1 enlargement treatment, or we’ll refund your money in full.
We don’t believe that a “ligament release” results in increased penile length except in a small minority of cases, as described in detail in ligament release procedure’s overview.
Some situations as described below are excluded from our 1-inch length extension guarantee.
While we will try our best to add as much length as these patients have available, we may not be able to achieve a 1-inch improvement in these cases:
Who may not qualify for the 1-inch guarantee (and why)
Most candidates who qualify for MegaMAXL® 6:1 meet or exceed the guaranteed minimum. However, a guarantee has to be tied to predictability—and predictability depends on tissue availability, anatomy, healing biology, and what has been altered before.
Below are the most common reasons the guarantee may not apply. In many of these cases, length improvement is still possible—we simply won’t promise a fixed number until your anatomy is confirmed.
1) Combined length + girth in one operation (PERMMAXL® / PermMAXL®)
When lengthening and all-natural girth are performed together, multiple tissues are healing and remodeling at the same time. That combined complexity can create more variability in how much visible length is retained during recovery (swelling, scar dynamics, and tissue settling). Many patients still gain meaningful length, but the biology is less “single-variable,” so a minimum number becomes less defensible.
2) Prior length surgery or prior enhancement with significant internal scarring
Previous surgery can change the internal “glide planes,” connective attachments, and elasticity that repositioning relies on. Even when a patient’s description is accurate, what we find internally can be very different. Scar tissue can limit mobilization, change resting position, or reduce how much length can be safely stabilized—so we may proceed, but without a minimum guarantee until we evaluate the true anatomy.
3) Micropenis diagnosis (true micropenis vs. “lost visible length”)
In true micropenis, both external and internal tissue dimensions can be smaller, and there may be less available structure to reposition outward. That doesn’t mean improvement isn’t possible—it often is—but the absolute “room to gain” can be more limited and varies widely case-to-case. We typically treat these patients with a more individualized plan and set expectations after direct evaluation.
4) Active Peyronie’s disease, significant curvature, or unresolved fibrosis
If there is active plaque, curvature, or unstable scarring, the priority is restoring/maintaining function and symmetry. Lengthening does not “fix” Peyronie’s, and operating in a tissue environment that’s actively remodeling can make final length outcomes less predictable. Many patients can pursue length goals after stabilization or appropriate treatment, but guarantees are usually deferred until the disease state is controlled.
5) Congenital conditions (e.g., hypospadias history, congenital curvature/chordee)
These cases can involve atypical tissue arrangement, prior repairs, urethral considerations, or baseline asymmetries. Even though Rejuvall’s technology was informed by complex reconstructive work, congenital anatomy can limit predictability for a standardized guarantee. We often can improve length and appearance, but guarantees depend on the individual pattern and prior surgical history.
6) Existing penile prosthesis (or device-dependent anatomy)
If a prosthesis is present, length is constrained by the device and the tissue envelope around it. Repositioning may be limited while the device remains in place, and safety/function must take priority.
7) Prior implant-based augmentation or prior foreign-material complication work
When a patient has had implant-based augmentation or prior intervention involving non-standard injected material, our initial goal is often restoration (reducing scar burden, improving contour, and protecting sensation/function). That “repair-first” reality changes what can be promised in one step. Length can sometimes be improved, but the guarantee is typically deferred because the clinical priority is stabilizing anatomy safely.
8) Buried anatomy / significant suprapubic fat pad (weight-related or genetic)
In men with buried anatomy, visible length is often limited by external concealment and downward pressure rather than “lack of penile tissue.” If we lengthen without addressing the concealment driver, new length can be mechanically pulled back inward and the stabilization mechanics are less reliable. In these cases, LifeSize® (fat pad correction + contouring + repositioning/repair if needed) is usually the medically appropriate first step—after which length outcomes become much more predictable.
9) Severe metabolic or healing risk factors (uncontrolled diabetes, heavy smoking, etc.)
Lengthening predictability depends on healthy tissue response and safe healing. Uncontrolled metabolic risk factors can increase complication risk and also change how tissue settles, scars, and stabilizes during recovery. Some patients can still be treated, but guarantees are not offered unless key health metrics meet safety thresholds—because safety has to come first.
10) Age-related tissue limitations (typically 62+)
After ~60, tissue elasticity, vascular dynamics, and connective tissue compliance become more variable—even in men who feel “healthy.” Some men in their 70s respond well; some men near 60 respond less predictably. Because the response range widens with age, guarantees are typically limited past a cutoff where predictability no longer meets our minimum standard.
Important note
None of the above automatically means “you can’t be helped.” It means we may recommend a different pathway (MAXL®, LifeSize®, reconstructive-first planning, or staged sequencing) or we may proceed without a minimum guarantee until the evaluation confirms what’s anatomically realistic and safe.
Rejuvall 2-Inch Length Guarantee (SuperMAXL® Pathway)
The 2-inch guarantee is achieved through a staged protocol: MAXL® non-surgical lengthening first, followed by MegaMAXL® surgical repositioning for qualified candidates.
This sequencing is designed to optimize tissue readiness and support larger, more reliable visible length improvement while protecting function and stability.
Through surgical penile repositioning, we have been able to increase penis length in every case by at least 1 inch with this penis enlargement surgery.
Some men have the good fortune to have a larger penis located directly behind the pelvic bone.
Dr. Carney began to notice, however, that about 50% of the repositioning surgical candidates on whom he performed penis enlargement surgery had more organ available to reposition outward, but they didn’t have enough shaft skin to get there.
Aware of Rejuvall’s success in restoring length to our Peyronie’s patients, he realized that by combining these two innovations, we could add at least 2 inches to the penile length of every suitable patient.
That’s how our revolutionary 2-inch lengthening guarantee was born.
Eligibility and exclusions are similar to the 1-inch guarantee and are reviewed prior to scheduling.
Who may not qualify for the 2-inch length guarantee (and why)
Rejuvall’s 2-inch guarantee is a staged pathway (typically MAXL® first → MegaMAXL® 6:1 next). Because the promise is larger, the requirements for predictability are tighter: we have to know you have enough internal length available, enough shaft skin/elasticity to support it, and a stable healing environment to lock in the gain safely.
Below are the most common reasons the 2-inch guarantee may not apply. In many of these cases, patients can still gain meaningful length—just not under a fixed minimum promise.
1) You can’t complete the staged sequence (MAXL® → MegaMAXL®)
The 2-inch guarantee depends on sequencing because MAXL® helps condition tissue and optimize the “platform” before surgical repositioning. If someone can’t complete that sequence (timing, adherence, travel constraints, or medical reasons), outcomes become more variable—so the guarantee doesn’t apply.
Plain-language why: the 2-inch promise isn’t a single procedure—it’s a controlled process.
2) Buried anatomy / significant fat pad concealment (weight-related or genetic)
If a suprapubic fat pad is concealing the shaft, visible length is limited by mechanics (concealment + downward pressure), not simply by “lack of lengthening.” In these cases, adding length without correcting concealment can cause the new length to be pulled back inward, making a 2-inch minimum unreliable.
Best-fit pathway instead: LifeSize® first to restore visibility and stabilize anatomy, then discuss staged length.
3) Prior penile length surgery or multiple prior enhancement procedures
Previous interventions often change internal attachments and healing planes. Scar tissue can reduce how much length can be safely mobilized, and it can reduce how reliably length can be stabilized after repositioning. The 2-inch guarantee requires a more predictable baseline than most revision anatomy can offer.
Plain-language why: repeat surgery is less “engineering” and more “reconstruction.”
4) True micropenis diagnosis (vs. lost visible length)
In true micropenis, internal and external structures may be smaller, which can limit available tissue to reposition and how much can be safely gained. Some micropenis patients still achieve major improvement, but the range is wider and a 2-inch minimum can’t be promised responsibly without direct evaluation.
Plain-language why: the “starting materials” vary more dramatically.
5) Active Peyronie’s disease, significant curvature, or unstable fibrosis
The 2-inch pathway assumes stable tissue that will remodel predictably. Active plaque or unstable curvature can change how tissue heals and how length presents over time. The priority is protecting erectile function and symmetry first; length planning becomes more predictable only after stabilization.
What we do instead: treat/stabilize first, then reassess staged length options.
6) Congenital conditions (hypospadias history, chordee/congenital curvature)
Congenital anatomy and prior repairs can affect tissue elasticity, skin distribution, and urethral considerations. Even if length is achievable, the predictability required for a 2-inch promise isn’t always present until the specific anatomy is confirmed.
Plain-language why: baseline anatomy is non-standard, so standardized promises don’t fit.
7) Existing penile prosthesis or implant-dependent anatomy
If a prosthesis is present, length is constrained by the device and the tissue envelope around it. Surgical planning becomes centered on function and device strategy. Because the implant defines the mechanical ceiling, a 2-inch guarantee generally can’t be offered while the device remains in place.
Plain-language why: the device becomes the limiting factor, not the technique.
8) Prior implant-based augmentation or prior foreign-material complications
When prior interventions involved implant removal, significant scar, or foreign-material complication work, the first objective is usually restoration—protecting sensation/function, reducing scar burden, and rebuilding stability. That “repair-first” reality makes a 2-inch minimum promise unreliable in one staged pathway.
Plain-language why: restoration work changes priorities and predictability.
9) Healing-risk factors (uncontrolled diabetes, heavy smoking, poor vascular health)
A larger guarantee requires especially reliable healing and stabilization. Risk factors that increase complication rates or change scar behavior also increase variability in final length retention. In these situations, we either require optimization first or proceed without a minimum guarantee.
Plain-language why: safety and predictable tissue response are non-negotiable for a 2-inch promise.
10) Age-related elasticity limitations (often 62+)
The 2-inch pathway depends heavily on tissue elasticity and how reliably tissue stabilizes after repositioning. As age increases, variability in connective tissue compliance and vascular responsiveness increases—even among “healthy” men. Because the response range widens, a 2-inch minimum can’t be promised in a way that stays medically defensible.
Plain-language why: biology becomes less uniform, so predictability drops.
If you don’t qualify for the 2-inch guarantee, you still have options
Not qualifying for a 2-inch guarantee doesn’t mean “no improvement.” It usually means one of these is more appropriate:
- MAXL® alone to build measurable length without surgery
- MegaMAXL® 6:1 with a 1-inch guarantee (when appropriate)
- LifeSize® first if concealment is the limiter
- Stabilize-first planning (Peyronie’s, metabolic risk factors, revision anatomy)
FAQs: Rejuvall Guaranteed Length Options
These guarantees apply to penile length for qualified candidates. Specifically, they are tied to Rejuvall’s length pathways (MegaMAXL® / SuperMAXL®) and standardized measurement methods. Girth enhancement is planned separately and is not part of these length guarantees.
Length is measured using a standardized clinical technique so comparisons are consistent and documented. The guarantee is based on visible flaccid length improvement (not a subjective “hang” impression). Your team will explain the exact measurement method used and how it’s documented for your case.
Most men who are good candidates for MegaMAXL® 6:1 lengthening qualify for the 1-inch minimum guarantee. Predictability is highest when:
- you have not had prior length surgery,
- your anatomy supports safe repositioning,
- and your health/healing factors meet screening standards.
Eligibility is confirmed during your clinical consult so the guarantee is tied to real anatomy—not assumptions.
The 2-inch guarantee is a staged pathway (MAXL® first → MegaMAXL® next) and requires stronger predictability. Candidates usually need:
- enough internal length available to reposition,
- enough tissue/skin capacity to support the staged change,
- and a stable healing profile.
Your clinical consult confirms whether the full staged sequence is medically appropriate.
Prior surgery or significant scar tissue can reduce predictability because internal tissue planes and attachments may be altered. That doesn’t mean you can’t improve—many men still can—but guarantees may not apply.
If visible length is limited by a suprapubic fat pad or buried/hidden anatomy, lengthening alone may not hold the way you want because concealment mechanics can pull tissue back inward. In those cases, LifeSize® correction is often the medically appropriate first step, and length planning becomes much more predictable after visibility is restored.
Yes. The 2-inch guarantee is designed around a staged plan because MAXL® helps condition tissue and improve readiness before surgical repositioning. If the staged sequence can’t be completed, the 2-inch guarantee won’t apply.
Yes. Not qualifying for a guarantee doesn’t mean “no improvement.” It usually means your safest lengthening plan is one of the following:
- MAXL® as a standalone path,
- MegaMAXL® without a minimum guarantee (based on your anatomy),
- LifeSize® if concealment is the limiter,
- stabilization-first planning if Peyronie’s, metabolic risks, or revision anatomy are present.
The goal is the same either way: a medically appropriate plan that protects function, symmetry, and long-term stability.
A note on mislabeled “permanent filler”
Some patients are told they’re receiving “PMMA” or a “collagen-stimulating permanent filler,” but later discover the injected substance was not Bellafill® PMMA. In some cases it may be a non-standard or non-medical material that becomes difficult to remove.
In the U.S., the only FDA-approved PMMA product is Bellafill®.
If a clinic cannot verify the exact product name, lot documentation, and medical oversight, treat that as a red flag, especially for permanent claims.
Find out if you qualify for a guaranteed length plan
Start with a confidential phone consult with our Patient Education Manager. He’ll review your goals, anatomy factors, and candidacy for MegaMAXL® (1-inch) or SuperMAXL® (2-inch) pathways—plus alternatives like MAXL® or LifeSize® when those are the safer fit.
